
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
HUDCO reported a modest rise in Q4 FY25 profit alongside sharp revenue growth, announced a final dividend, and highlighted strong loan book expansion and fundraising plans.
JSW Kalinga Steel plans ₹9,500 crore zero-coupon NCDs to fund shareholder loans linked to the BPSL slump sale and JSW Steel-JFE joint venture structure.
JSW Steel’s March-quarter profit surged to ₹19,243 crore as an ₹18,051 crore one-time gain from the Bhushan Power steel-operations slump sale lifted earnings despite normal operations.
HUDCO’s Q3 FY25–26 results show revenue from operations rising 24.3% YoY to ₹3,431 crore, while net profit slipped 3.0% YoY to ₹713 crore amid higher costs.
Patel Engineering’s recent disclosures show FY25 revenue crossing ₹5,000 crore, a ₹15,218 crore order book, lower gross debt, and mixed quarterly profit figures amid exceptional items.
Kaynes Technology posted FY26 revenue of ₹3,626.4 crore and guided 30% FY27 growth, even as Q4 profit fell and working capital stayed elevated.
Hindustan Aeronautics reported Q4 FY26 net profit of ₹4,196 crore aided by a sharp rise in other income, while revenue grew 1.7% and shares gained 4%.
DLF reported a 1% YoY dip in Q4 FY26 profit to ₹1,268.56 crore as revenue fell 42%, while FY26 profit rose 1% and the board proposed a ₹8 dividend.
Bajaj Finance’s Q2 FY26 results showed strong profit and income growth, but the stock fell nearly 7% after management cut FY26 AUM guidance and NPAs rose.
Indraprastha Gas approved a maiden 1:1 bonus issue, raising paid-up capital to ₹280 crore, with an ex-date of Jan 31, 2025 and reserves-backed funding.
Avalon Technologies (AVALON) traded around ₹1,267-₹1,292 on 14 May 2026, with 52-week levels, market cap snapshots, and return data highlighting recent volatility.
Stock market today: Nifty today jumped 1.18% and Sensex today rose 790 points as banks, metals and pharma led a broad rebound despite hot WPI inflation.
OneSource Specialty Pharma reaffirmed FY28 guidance after a weak Q3FY26 hit by delayed semaglutide approvals, while stepping up capacity expansion and commercial shipments in India and Canada.
Akums Drugs reported FY26 consolidated revenue of ₹43,590.17 million and recommended a ₹3.00 per share dividend, with the AGM scheduled for July 10, 2026.
Caplin Point Laboratories reported higher Q3 FY26 profit and sales, while investors tracked USFDA approval updates, dividend trends, and valuation metrics like PE, PB, and 52-week levels.
Meghmani Organics hit fresh 52-week and all-time lows amid a weak week for equities, as losses, falling sales and rising interest costs kept sentiment cautious.